Abstract
Adult onset Still's Disease (ASD) is a systemic inflammatory disorder of unknown etiology characterized by chronic and fluctuant fever with accompanying rash, polyarthritis and involvement of multiple organs, especially lymphoid tissues. Although kidney involvement may appear in some cases of adult Still's disease, membranous glomerulonephyritis has not been described before. We herein report a 38-year-old man diagnosed with Still's disease with longstanding polyarthritis unresponsive to high-dose steroids and various immunosuppressive drugs for 5 years. He was referred to our clinic with bilateral pretibial edema on his legs. Urine examination revealed 10.5 g/day proteinuria with membranous glomerulonephritis and his renal biopsy came up with it. Infliximab was initiated, and his complaints were totally resolved also with a normal urine test in the following 3 months. To the best of our knowledge, this is the first report that clearly shows the efficacy of infliximab in a patient with refractory ASD with membranous glomerulonephyritis.
This is a preview of subscription content, log in via an institution to check access.
References
Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still's disease. J Rheumatol 19:424–430
Austin HA, Antonovych TT, MacKay K et al (1992) NIH Conference. Membranous nephropathy. Ann Intern Med 116:672–678
Kumar S, Sheaff M, Yaqoob M (2004) Collapsing glomerulopathy in adult Still's disease. Am J Kidney Dis 43:4–10
Wendling D, Hory B, Blanc D (1990) Adult Still's disease and mesangial glomerulonephritis. Report of two cases. Clin Rheumatol 9:95–99
Portoles J, de Tomas E, Espinosa A et al (1997) Thrombotic thrombocytopenic purpura and acute renal failure in adult Still’s disease. Nephrol Dial Transplant 12:1471–1473
Rivera F, Gill CM, Gill MT et al (1997) Vascular renal AA amyloidosis in adult Still's disease. Nephrol Dial Transplant 12:1714–1716
Lai KN, Li PK, Lui SF et al (1991) Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324:1457–1463
Rollino C, Roccatello D, Giachino O et al (1991) Hepatitis C virus infection and membranous glomerulo-nephritis. Nephron 59(2):319–320
Castanet J, Lacour JP, Fuzibet JG et al (1994) Adult Still's disease associated with hepatitis C virus infection. J Am Acad Dermatol 31:807–808
Gambichler T, Paech V, Roterrdam S et al (2003) Hepatitis B-assocciated adult-onset Still's disease presenting with neutrophilic urticaria. Eur J Med Res 8(12):527–530
Fujii T, Nojima T, Yasuoka H et al (2001) Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology Oxford 40:1398–1404
Neale TJ, Rüger BM, Macaulay H et al (1995) Tumor necrosis factor alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol 146(6):1444–1454
Honkanen E, Teppo AM, Meri S et al (1994) Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 9(11):1553–1559
Lehto T, Honkanen E, Teppo AM, Meri S (1995) Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. Kidney Int 47(5):1403–1411
Chen DY, Lan JY, Lin FJ et al (2004) Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 31(11):2189–2198
Hoshino T, Ohta A, Yang D et al (1998) Elevated serum interleukin 6, interferon-γ, and tumor necrosis factor-a levels in patients with adult Still's disease. J Rheumatol 25:396–398
Cavagna L, Caporali R, Epis O et al (2001) Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 19:329–332
Asherson RA, Pascoe L (2002) Adult onset Still's disease response to Enbrel. Ann Rheum Dis 61:859–860
Kraetsch HG, Antoni C, Kalden JR et al (2001) Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 60(Suppl 3):iii55–57
Bonilla Hernán MG, Cobo Ibáñez T, de Miguel Mendieta E et al (2004) Infliximab (anti- TNF- alpha) treatment in patients with adult Still's disease. Experience in 2 cases. An Med Interna 21(1):23–26
Caramaschi P, Biasi D, Carletto A, Bambara LM (2002) A case of adult onset Still's disease treated with infliximab. Clin Exp Rheumatol 20:113
Mukhtyar C, Luqmani R (2005) Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis. Ann Rheum Dis 64(Suppl 4):iv31–36
Aringer M, Graninger WB, Steiner G et al (2004) Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum 50:3161–3169
Fiehn C, Andrassy K (2004) Case number 29: hitting three with one strike: rapid improvement of psoriatic arthritis, psoriatic erythroderma, and secondary renal amyloidosis by treatment with infliximab (Remicade). Ann Rheum Dis 63(3):232
Thonhofer R, Soleiman A, Kriessmayr M et al (2006) Decrease of proteinuria in a patient with adult-onset Still's disease and glomerulonephritis after anti-TNF alpha therapy. Scand J Rheumatol 35(6):485–488
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Babacan, T., Onat, A.M., Pehlivan, Y. et al. Successful treatment of refractory adult still’s disease and membranous glomerulonephritis with infliximab. Clin Rheumatol 29, 423–426 (2010). https://doi.org/10.1007/s10067-009-1331-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-009-1331-8